[
  {
    "ts": null,
    "headline": "Centene: High-Risk Buy With Huge Potential",
    "summary": "Centene Corporation faces short-term cost challenges, but offers long-term upside if margins recover. Click for more on CNC stock prospects.",
    "url": "https://finnhub.io/api/news?id=f91b901c1155356e5481dda94f4369807ca908d84bb15a0077be41342daa4452",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761053671,
      "headline": "Centene: High-Risk Buy With Huge Potential",
      "id": 137180103,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2204623643/image_2204623643.jpg?io=getty-c-w1536",
      "related": "CNC",
      "source": "SeekingAlpha",
      "summary": "Centene Corporation faces short-term cost challenges, but offers long-term upside if margins recover. Click for more on CNC stock prospects.",
      "url": "https://finnhub.io/api/news?id=f91b901c1155356e5481dda94f4369807ca908d84bb15a0077be41342daa4452"
    }
  },
  {
    "ts": null,
    "headline": "Assessing Centene’s Value After 12% Stock Rebound and Medicaid Contract Expansion",
    "summary": "Trying to decide what to do with Centene's stock? You are not alone. With shares closing recently at $35.61 and a valuation score of 5 out of a possible 6, this healthcare insurer keeps investors guessing. The past month saw Centene gaining a robust 12.1%, a sharp turnaround after a tough stretch that included a year-to-date tumble of 41.2% and a staggering 57.4% three-year loss. Clearly, sentiment has shifted recently, but the big question is, why? Some of this volatility can be traced to...",
    "url": "https://finnhub.io/api/news?id=f9577e7f7aa4fd5e5be7a6c197eef3d7a67d624b90428a4e2b53193cd191222d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761034123,
      "headline": "Assessing Centene’s Value After 12% Stock Rebound and Medicaid Contract Expansion",
      "id": 137174937,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CNC",
      "source": "Yahoo",
      "summary": "Trying to decide what to do with Centene's stock? You are not alone. With shares closing recently at $35.61 and a valuation score of 5 out of a possible 6, this healthcare insurer keeps investors guessing. The past month saw Centene gaining a robust 12.1%, a sharp turnaround after a tough stretch that included a year-to-date tumble of 41.2% and a staggering 57.4% three-year loss. Clearly, sentiment has shifted recently, but the big question is, why? Some of this volatility can be traced to...",
      "url": "https://finnhub.io/api/news?id=f9577e7f7aa4fd5e5be7a6c197eef3d7a67d624b90428a4e2b53193cd191222d"
    }
  },
  {
    "ts": null,
    "headline": "Centene: Strong Buy, For All The Wrong Reasons",
    "summary": "Centeneâs moat faces challenges, but current valuation suggests opportunity. Read why any recovery could mean significant upside for CNC stock.",
    "url": "https://finnhub.io/api/news?id=9de5a41fb98dee06f16a02fc69400a2b7173c137729e879c9a74c76b66eb0604",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761021536,
      "headline": "Centene: Strong Buy, For All The Wrong Reasons",
      "id": 137173664,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1022141470/image_1022141470.jpg?io=getty-c-w1536",
      "related": "CNC",
      "source": "SeekingAlpha",
      "summary": "Centeneâs moat faces challenges, but current valuation suggests opportunity. Read why any recovery could mean significant upside for CNC stock.",
      "url": "https://finnhub.io/api/news?id=9de5a41fb98dee06f16a02fc69400a2b7173c137729e879c9a74c76b66eb0604"
    }
  }
]